Stock Down Under

Money-Making Insights On

ASX-Listed Stocks

Find Us in

Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.

The $3m super tax is coming! If you’re invested in equities, here is how it might impact you

By Nick Sundich | May 9, 2025

It seems during the next 3 years, the $3m super tax will be officially a thing. Itwas blocked by the Senate and shelved by the government, until after the next election. Treasurer Jim Chalmers explicitly labelled it ‘unfinished business’. Now that Labor has been re-elected, and it needs only obtain the support of the Greens…

Read More

Northern Star Resources (ASX:NST): The $28bn gold miner that stands above them all

By Ujjwal Maheshwari | May 9, 2025

Northern Star Resources (ASX:NST) is by far the largest gold company on the ASX, capped at $28bn as of May 2025. Although Newmont (which bought Newcrest and since the purchase, has its CDIs listed on the ASX) is a larger company, only a minority of its shares are listed on the ASX. What makes NST…

Read More

6 ASX stocks you forgot were listed

By Nick Sundich | May 8, 2025

Here are 6 ASX stocks you forgot were listed   Brisbane Broncos (ASX:BBL) No it is not a mistake. This $100m company is none other than Brisbane’s first NRL team. And while it is no ASX 200 company, the Red Hill-based team made $81.6m in revenue (up 9%) and a $5.7m post-tax profit (up 2%)…

Read More

Inghams shares have been volatile in the last 12 months, but better times might be ahead

By Nick Sundich | May 8, 2025

It has been a while since we last wrote about Inghams shares (ASX:ING) – 8 months to be exact. It was in the immediate aftermath of the poultry company’s FY24 results that investors loathed, sending them down 20% in a day. This was actually the second time Inghams shares crashed after releasing results, because a…

Read More

Its reporting season in New Zealand in May and these 5 ASX companies are about to report annual results

By Nick Sundich | May 7, 2025

Its always reporting season in New Zealand in May as well as November, because many companies there follow an April 1-March 31 financial year. While there are some exemptions that follow the calendar or Australian financial years (July to June), many Kiwi companies still use the Kiwi financial year. And they can do so as…

Read More

Immutep (ASX:IMM): Set to commercialise its lung cancer treatment by 2027

By Nick Sundich | May 7, 2025

Developing a cancer drug is a long journey, but Immutep (ASX:IMM) is more towards the end than the start. A few months ago, when it received its latest capital injection (of $100m), the company told its investors it was less than three years away from commercialising its cancer drug. Immutep’s share price may not suggest…

Read More

The Latest OPEC Production Increase is 411,000 Barrels! Here’s What It Means for Global Oil Prices

By Ujjwal Maheshwari | May 6, 2025

The latest OPEC production increase could hit oil prices hard. OPEC (Organisation of the Petroleum Exporting Countries) has decided to increase oil production by 411,000 barrels per day (bpd) has made headlines, sparking debates within the energy markets. As one of the most influential groups in global energy production (f not the most, OPEC’s policies…

Read More

Labor’s 2025 Win: 5 Stocks Set to Soar Under the New Government

By Ujjwal Maheshwari | May 6, 2025

As Australia heads into a new political era with Labor’s win in 2025, investors are paying close attention to the policies that will shape the economy over the next few years. Labor’s agenda, which includes a strong commitment to renewable energy, healthcare reform, infrastructure projects, and tourism recovery, presents significant investment opportunities. In our view,…

Read More

This Phase 3 ASX biotech is on the brink of unlocking market opportunities worth a cumulative US$9.1bn

By Nick Sundich | May 6, 2025

Recce Pharmaceuticals (ASX:RCE,  FSE:R9Q) is a Phase 3 ASX biotech that is close to unlocking its market opportunity. It is expecting to complete its Phase 3 trials during FY26 (the 12 months starting on July 1, 2025), and success here would lead to unlocking of market opportunities worth a cumulative US$9.1bn. Specifically, the global DFI…

Read More

Which will be the next ASX gold stocks to be acquired? Here are 3 possible candidates

By Nick Sundich | May 6, 2025

Investors are wondering which will be the next ASX gold stocks to be acquired. There has been a flurry of M&A activity this year, the latest deal of which was confirmed to go ahead yesterday with Gold Roads being bought by Gold Fields for $3.9bn. There have been other deals too including a merger between…

Read More

Sector Analysis

The-Best-Mining-Stocks

The Best Mining Stocks

Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.

The-Best-Tech-Stocks

The Best Tech Stocks

Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.

The-Best-Uranium-Stocks

The Best Uranium Stocks

Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.

Untitled design

The Best Healthcare Stocks

There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.

The-Best-Mining-Stocks

The Best Mining Stocks

The-Best-Tech-Stocks

The Best Tech Stocks

The-Best-Uranium-Stocks

The Best Uranium Stocks

Share Type Analysis

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now. 

The Best ASX Stocks Right Now

The Best ASX Stocks Right Now

The Top Penny Stocks

The Top Penny Stocks

Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.

The Top Penny Stocks

The Top Penny Stocks

The Top Dividend Stocks

The Top Dividend Stocks

Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.

The Top Dividend Stocks

The Top Dividend Stocks

size set 1

Top ASX Index Funds

Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.

size set 1

Top ASX Index Funds

size 2

The Top Blue Chip Stocks

Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.

size 2

The Top Blue Chip Stocks

size 3

Top ASX Growth Stocks for Investing

Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.

size 3

Top ASX Growth Stocks for Investing

Webinars and Interviews

BrainChip’s ambitious technology roadmap unlocks many GenAI applications

BrainChip (ASX:BRN) In a recent interview with BrainChip (ASX:BRN) CEO Sean Hehir, we talked about the…

Battery Age Minerals (ASX:BM8) reports much higher than expected germanium grades

Battery Age Minerals (ASX: BM8) We spoke with Nigel Broomham, CEO of Battery Age Minerals (ASX:…

Firstwave Cloud Technology (ASX:FCT) has pivoted towards high-growth markets

Firstwave Cloud Technology (ASX:FCT) We spoke with Danny Maher, CEO of Firstwave Cloud Technology (ASX:FCT), about…

Truscreen (ASX:TRU) is gaining momentum in a diverse range of jurisdictions

Truscreen (ASX:TRU) We spoke to Marty Dillon, CEO of Truscreen (ASX:TRU) about the progress TRU has…

Investment Glossary

Small Cap Company

What Is a Small Cap Company? A Complete Guide for Investors

September 24, 2024

Overview of Small Cap Companies…

All Ordinaries Index

What is the All Ordinaries Index and How Does It Work?

September 20, 2024

The All Ordinaries Index, also…

What is Commodity?

What is Commodity? Understanding Commodity Trading

May 23, 2024

Introduction to Commodities Commodities are…

Securities

Overview of Securities in the Australian Financial Market

May 23, 2024

What is a security? Security refers…

IPO

What Is an IPO? Understanding Initial Public Offerings

May 23, 2024

What is IPO? An Initial Public…

The Team Behind Stocks Down Under

1rw

Stuart Roberts

Co-Founder

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research

Marc-circle-300x300_webp

Marc Kennis

Co-Founder

Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,

The Team Behind Stocks Down Under

STUART ROBERTS

Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.

MARC KENNIS

Marc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.

PETER KILBY

Pete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.

Please enter your name.
Please enter a message.